|

hyperpolarized pyruvate +/-urea (13C/15N) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 13C-Pyruvate,15N-urea

Pipeline

Phase 2: 1

Top Sponsors

  • Robert Bok, MD, PhD1

Indications

  • Prostate Cancer1
  • Cancer1

San Francisco, California1 trial

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

University of California, San Francisco

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.